肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

ESMO共识会议建议：转移性黑色素瘤的管理

2020-07-22 欧洲肿瘤内科学会 Ann Oncol . 2020 Jul 22;

转移性黑色素瘤

欧洲肿瘤内科学会(ESMO)召开了黑色素瘤共识会议，本次会议的主要目的是针对ESMO未涵盖的主题制定指导建议，本文主要针对转移性黑色素瘤的管理提供指导建议。

中文标题：

ESMO共识会议建议：转移性黑色素瘤的管理

英文标题：

ESMO consensus conference recommendations on the management of metastatic melanoma: the ESMO Guidelines Committee

发布机构：

欧洲肿瘤内科学会

发布日期：

2020-07-22

简要介绍：

欧洲肿瘤内科学会(ESMO)召开了黑色素瘤共识会议，本次会议的主要目的是针对ESMO未涵盖的主题制定指导建议，本文主要针对转移性黑色素瘤的管理提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020ESMO共识会议建议：转移性黑色素瘤的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d2c471c0019536db, title=ESMO共识会议建议：转移性黑色素瘤的管理, enTitle=ESMO consensus conference recommendations on the management of metastatic melanoma: the ESMO Guidelines Committee, guiderFrom=Ann Oncol . 2020 Jul 22;, authorId=0, author=, summary=欧洲肿瘤内科学会(ESMO)召开了黑色素瘤共识会议，本次会议的主要目的是针对ESMO未涵盖的主题制定指导建议，本文主要针对转移性黑色素瘤的管理提供指导建议。, cover=https://img.medsci.cn/2020817/1597677513671_2020535.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Wed Jul 22 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>欧洲肿瘤内科学会(ESMO)召开了黑色素瘤共识会议，本次会议的主要目的是针对ESMO未涵盖的主题制定指导建议，本文主要针对转移性黑色素瘤的管理提供指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=5668, tagName=转移性黑色素瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=5668, guiderKeyword=转移性黑色素瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1367, appHits=72, showAppHits=0, pcHits=368, showPcHits=1295, likes=1, shares=3, comments=5, approvalStatus=1, publishedTime=Mon Aug 17 23:41:12 CST 2020, publishedTimeString=2020-07-22, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Aug 17 23:18:40 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:32:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020ESMO共识会议建议：转移性黑色素瘤的管理.pdf)])
2020ESMO共识会议建议：转移性黑色素瘤的管理.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1222344, encodeId=a87b1222344d7, content=恶性黑色素瘤骨转移，有没有指导性建议？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794f8178901, createdName=ms9000000314102385, createdTime=Wed May 25 15:53:02 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811586, encodeId=1528811586a8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/0d7afbf7f68e4ce6802c8a3de6936ca8/236a200991fa45ae8da27362b7250b28.jpg, createdBy=5b6d3202096, createdName=12c1fc26m47暂无昵称, createdTime=Thu Aug 20 22:09:06 CST 2020, time=2020-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810818, encodeId=5dd581081841, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:52:01 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810817, encodeId=686781081ecd, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:51:58 CST 2020, time=2020-08-19, status=1, ipAttribution=)]
    2022-05-25 ms9000000314102385

    恶性黑色素瘤骨转移，有没有指导性建议？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1222344, encodeId=a87b1222344d7, content=恶性黑色素瘤骨转移，有没有指导性建议？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794f8178901, createdName=ms9000000314102385, createdTime=Wed May 25 15:53:02 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811586, encodeId=1528811586a8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/0d7afbf7f68e4ce6802c8a3de6936ca8/236a200991fa45ae8da27362b7250b28.jpg, createdBy=5b6d3202096, createdName=12c1fc26m47暂无昵称, createdTime=Thu Aug 20 22:09:06 CST 2020, time=2020-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810818, encodeId=5dd581081841, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:52:01 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810817, encodeId=686781081ecd, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:51:58 CST 2020, time=2020-08-19, status=1, ipAttribution=)]
    2020-08-20 12c1fc26m47暂无昵称

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1222344, encodeId=a87b1222344d7, content=恶性黑色素瘤骨转移，有没有指导性建议？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794f8178901, createdName=ms9000000314102385, createdTime=Wed May 25 15:53:02 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811586, encodeId=1528811586a8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/0d7afbf7f68e4ce6802c8a3de6936ca8/236a200991fa45ae8da27362b7250b28.jpg, createdBy=5b6d3202096, createdName=12c1fc26m47暂无昵称, createdTime=Thu Aug 20 22:09:06 CST 2020, time=2020-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810818, encodeId=5dd581081841, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:52:01 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810817, encodeId=686781081ecd, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:51:58 CST 2020, time=2020-08-19, status=1, ipAttribution=)]
    2020-08-19 ms5000000741733160

    ！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1222344, encodeId=a87b1222344d7, content=恶性黑色素瘤骨转移，有没有指导性建议？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794f8178901, createdName=ms9000000314102385, createdTime=Wed May 25 15:53:02 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811586, encodeId=1528811586a8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/0d7afbf7f68e4ce6802c8a3de6936ca8/236a200991fa45ae8da27362b7250b28.jpg, createdBy=5b6d3202096, createdName=12c1fc26m47暂无昵称, createdTime=Thu Aug 20 22:09:06 CST 2020, time=2020-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810818, encodeId=5dd581081841, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:52:01 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810817, encodeId=686781081ecd, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:51:58 CST 2020, time=2020-08-19, status=1, ipAttribution=)]
    2020-08-19 ms5000000741733160

    👍

    0